To approach the design of CPPs able to preserve TrkB‐FL levels in excitotoxicity and ischemia, we focused in the receptor inter‐domain sequence located between the TM and proximal TK domains (aa 453–536) for several reasons. The gene discussed is TKT; the disease is ischemia.